Risk assessment and clinical implications of COVID-19 in multiple myeloma patients: A systematic review and meta-analysis.

ABSTRACT:

Introduction

Patients with multiple myeloma (MM) face heightened infection susceptibility, particularly severe risks from COVID-19. This study, the first systematic review in its domain, seeks to assess the impacts of COVID-19 on MM patients.

Method

Adhering to PRISMA guidelines and PROSPERO registration (ID: CRD42023407784), this study conducted an exhaustive literature search from January 1, 2020, to April 12, 2024, using specified search terms in major databases (PubMed, EMBASE, and Web of Science). Quality assessment utilized the JBI Critical checklist, while publication bias was assessed using Egger's test and funnel plot. The leave-one-out sensitivity analyses were performed to assess the robustness of the results by excluding one study at a time to identify studies wi

SUBMITTER: Mahmud S 

PROVIDER: S-EPMC11379232 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature